A shortcut to the use of AI in healthcare is its use in medical administration
By Satyen K. Bordoloi  |  Aug 19, 2022
A shortcut to the use of AI in healthcare is its use in medical administration
Image courtesy of and under license from Shutterstock.com
The USA spends trillions of dollars a year on healthcare paperwork. Automated solutions made possible by ML and AI not only mean much of this money can be saved, but also makes largescale adoption of AI more likely before highly regulated medical AI reaches critical mass, finds Satyen K. Bordoloi.

MUMBAI - Of the more than USD4 trillion that the United States spends on healthcare ever year, what does it spend the most on? Harvard Economics Prof David M. Cutler, a key advisor to both Presidents Obama and Clinton, begins his March 2020 paper1 for the Brookings Institution’s The Hamilton Project economic policy initiative with the startling fact that administrative costs account for over a quarter - and possibly as much as two-thirds - of this amount, i.e., twice as much as what the US spends on heart disease or three times the amount spent on cancer.

Trillions of dollars spent on paperwork every year is simply Kafkaesque. Fortunately, as Cutler points out, this need not be the case. Many solutions are at hand to help address this, the newest being artificial intelligence (AI).

When one thinks of AI in healthcare, one of the first things that comes to mind is how lives can be saved by the miraculous cures AI promises, from precision medicine to personalized care. One never even realizes how AI can also save hundreds of billions of dollars spent on the badly managed administrative functions of medicine and healthcare.


Why AI curing diseases is still some way away

The promise of AI lies in the diagnosis, detection, and cure of diseases. One often reads about how AI is better at detecting cancers, COVID-19, and tuberculosis from mere X-rays, solving the protein folding problem, and discovering drugs. Such accomplishments have indeed been done, but the mass-scale adoption of most of these solutions is still years away, if not decades. The reason for this is simple: medicine is a highly regulated field. Agencies like the US Food and Drug Administration, Public Health in the European Union, the Central Drugs Standard Control Org

The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. The copying or storing of any content for anything other than personal use is expressly prohibited without prior written permission from The Yuan, or the copyright holder identified in the copyright notice contained in the content.
Continue reading
Sign up now to read this story for free.
- or -
Continue with Linkedin Continue with Google
Comments
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.